| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Protein Science, Vol 6, Issue 5 929-955, Copyright © 1997 by Cold Spring Harbor Laboratory Press
REVIEWS |
R. J. SIMPSON, A. HAMMACHER, D. K. SMITH, J. M. MATTHEWS and L. D. WARD
Joint Protein Structure Laboratory, Ludwig Institute for Cancer Research (Melbourne Tumour Biology Branch) and The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3050, Australia
Interleukin-6 (IL-6) is a multifunctional cytokine that plays a central role in host defense due to its wide range of immune and hematopoietic activities and its potent ability to induce the acute phase response. Overexpression of IL-6 has been implicated in the pathology of a number of diseases including multiple myeloma, rheumatoid arthritis, Castleman's disease, psoriasis, and post-menopausal osteoporosis. Hence, selective antagonists of IL-6 action may offer therapeutic benefits. IL-6 is a member of the family of cytokines that includes interleukin-11, leukemia inhibitory factor, oncostatin M, cardiotrophin-1, and ciliary neurotrophic factor. Like the other members of this family, IL-6 induces growth or differentiation via a receptor-system that involves a specific receptor and the use of a shared signaling subunit, gp130. Identification of the regions of IL-6 that are involved in the interactions with the IL-6 receptor and gp130 is an important first step in the rational manipulation of the effects of this cytokine for therapeutic benefit. In this review, we focus on the sites on IL-6 which interact with its low-affinity specific receptor, the IL-6 receptor, and the high-affinity converter gp130. A tentative model for the IL-6 hexameric receptor ligand complex is presented and discussed with respect to the mechanism of action of the other members of the IL-6 family of cytokines.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Metz, G. Naeth, P. C. Heinrich, and G. Muller-Newen Novel Inhibitors for Murine and Human Leukemia Inhibitory Factor Based on Fused Soluble Receptors J. Biol. Chem., March 7, 2008; 283(10): 5985 - 5995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Metz, M. Wiesinger, M. Vogt, H. Lauks, G. Schmalzing, P. C. Heinrich, and G. Muller-Newen Characterization of the Interleukin (IL)-6 Inhibitor IL-6-RFP: FUSED RECEPTOR DOMAINS ACT AS HIGH AFFINITY CYTOKINE-BINDING PROTEINS J. Biol. Chem., January 12, 2007; 282(2): 1238 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yang, M. A. Choudhry, Y.-C. Hsieh, S. Hu, L. W. Rue III, K. I. Bland, and I. H. Chaudry Estrus cycle: influence on cardiac function following trauma-hemorrhage Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2807 - H2815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Han, A. J. Demetris, D. B. Stolz, L. Xu, K. Lim, and T. Wu Modulation of Stat3 Activation by the Cytosolic Phospholipase A2{alpha} and Cyclooxygenase-2-controlled Prostaglandin E2 Signaling Pathway J. Biol. Chem., August 25, 2006; 281(34): 24831 - 24846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Stuhlmann-Laeisz, S. Lang, A. Chalaris, P. Krzysztof, S. Enge, J. Eichler, U. Klingmuller, M. Samuel, M. Ernst, S. Rose-John, et al. Forced Dimerization of gp130 Leads to Constitutive STAT3 Activation, Cytokine-independent Growth, and Blockade of Differentiation of Embryonic Stem Cells Mol. Biol. Cell, July 1, 2006; 17(7): 2986 - 2995. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. O Huising, C. P Kruiswijk, and G. Flik Phylogeny and evolution of class-I helical cytokines. J. Endocrinol., April 1, 2006; 189(1): 1 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Tabary, H. Corvol, E. Boncoeur, K. Chadelat, C. Fitting, J. M. Cavaillon, A. Clement, and J. Jacquot Adherence of airway neutrophils and inflammatory response are increased in CF airway epithelial cell-neutrophil interactions Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L588 - L596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Grimm, L. Six, C. Tomovski, P. Speiser, E. Joura, R. Zeillinger, G. Sliutz, A. Reinthaller, and L. A. Hefler A Common Interleukin-6 Promoter Polymorphism in Patients With Vulvar Cancer Reproductive Sciences, December 1, 2005; 12(8): 617 - 620. [Abstract] [PDF]
|
|
|
|
|
|
M. B. Meads and P. G. Medveczky Kaposi's Sarcoma-associated Herpesvirus-encoded Viral Interleukin-6 Is Secreted and Modified Differently Than Human Interleukin-6: EVIDENCE FOR A UNIQUE AUTOCRINE SIGNALING MECHANISM J. Biol. Chem., December 10, 2004; 279(50): 51793 - 51803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Dela Cruz, Y. Lee, S. R. Viswanathan, A. S. El-Guindy, J. Gerlach, S. Nikiforow, D. Shedd, L. Gradoville, and G. Miller N-linked Glycosylation Is Required for Optimal Function of Kaposi's Sarcoma Herpesvirus-encoded, but Not Cellular, Interleukin 6 J. Exp. Med., February 17, 2004; 199(4): 503 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. D. Fairlie, A. D. Uboldi, J. E. McCoubrie, C. C. Wang, E. F. Lee, S. Yao, D. P. De Souza, S. Mifsud, D. Metcalf, N. A. Nicola, et al. Affinity Maturation of Leukemia Inhibitory Factor and Conversion to Potent Antagonists of Signaling J. Biol. Chem., January 16, 2004; 279(3): 2125 - 2134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zabeau, D. Defeau, J. Van der Heyden, H. Iserentant, J. Vandekerckhove, and J. Tavernier Functional Analysis of Leptin Receptor Activation Using a Janus Kinase/Signal Transducer and Activator of Transcription Complementation Assay Mol. Endocrinol., January 1, 2004; 18(1): 150 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Trikha, R. Corringham, B. Klein, and J.-F. Rossi Targeted Anti-Interleukin-6 Monoclonal Antibody Therapy for Cancer: A Review of the Rationale and Clinical Evidence Clin. Cancer Res., October 15, 2003; 9(13): 4653 - 4665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. OSTERUD and E. BJORKLID Role of Monocytes in Atherogenesis Physiol Rev, October 1, 2003; 83(4): 1069 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Muller-Newen The Cytokine Receptor gp130: Faithfully Promiscuous Sci. Signal., September 23, 2003; 2003(201): pe40 - pe40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Boulanger, D.-c. Chow, E. E. Brevnova, and K. C. Garcia Hexameric Structure and Assembly of the Interleukin-6/IL-6 {alpha}-Receptor/gp130 Complex Science, June 27, 2003; 300(5628): 2101 - 2104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Man, W. He, K. H. Sze, K. Gong, D. K. Smith, G. Zhu, and N. Y. Ip Solution Structure of the C-terminal Domain of the Ciliary Neurotrophic Factor (CNTF) Receptor and Ligand Free Associations among Components of the CNTF Receptor Complex J. Biol. Chem., June 20, 2003; 278(26): 23285 - 23294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ancey, A. Kuster, S. Haan, A. Herrmann, P. C. Heinrich, and G. Muller-Newen A Fusion Protein of the gp130 and Interleukin-6Ralpha Ligand-binding Domains Acts as a Potent Interleukin-6 Inhibitor J. Biol. Chem., May 2, 2003; 278(19): 16968 - 16972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. Varghese, R. L. Moritz, M.-Z. Lou, A. van Donkelaar, H. Ji, N. Ivancic, K. M. Branson, N. E. Hall, and R. J. Simpson Structure of the extracellular domains of the human interleukin-6 receptor alpha -chain PNAS, December 10, 2002; 99(25): 15959 - 15964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Taverner, N. E. Hall, R. A. J. O'Hair, and R. J. Simpson Characterization of an Antagonist Interleukin-6 Dimer by Stable Isotope Labeling, Cross-linking, and Mass Spectrometry J. Biol. Chem., November 22, 2002; 277(48): 46487 - 46492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Greiser, C. Stross, P. C. Heinrich, I. Behrmann, and H. M. Hermanns Orientational Constraints of the gp130 Intracellular Juxtamembrane Domain for Signaling J. Biol. Chem., July 19, 2002; 277(30): 26959 - 26965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Deeble, D. J. Murphy, S. J. Parsons, and M. E. Cox Interleukin-6- and Cyclic AMP-Mediated Signaling Potentiates Neuroendocrine Differentiation of LNCaP Prostate Tumor Cells Mol. Cell. Biol., December 15, 2001; 21(24): 8471 - 8482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schaeffer, M. Schneiderbauer, S. Weidler, R. Tavares, M. Warmuth, G. de Vos, and M. Hallek Signaling through a Novel Domain of gp130 Mediates Cell Proliferation and Activation of Hck and Erk Kinases Mol. Cell. Biol., December 1, 2001; 21(23): 8068 - 8081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Aoki, M. Narazaki, T. Kishimoto, and G. Tosato Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus Blood, November 15, 2001; 98(10): 3042 - 3049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Li, H. Wang, and J. Nicholas Detection of Direct Binding of Human Herpesvirus 8-Encoded Interleukin-6 (vIL-6) to both gp130 and IL-6 Receptor (IL-6R) and Identification of Amino Acid Residues of vIL-6 Important for IL-6R-Dependent and -Independent Signaling J. Virol., April 1, 2001; 75(7): 3325 - 3334. [Abstract] [Full Text]
|
|
|
|
|
|
D.-c. Chow, X.-l. He, A. L. Snow, S. Rose-John, and K. C. Garcia Structure of an Extracellular gp130 Cytokine Receptor Signaling Complex Science, March 16, 2001; 291(5511): 2150 - 2155. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Pflanz, I. Kurth, J. Grotzinger, P. C. Heinrich, and G. Muller-Newen Two Different Epitopes of the Signal Transducer gp130 Sequentially Cooperate on IL-6-Induced Receptor Activation J. Immunol., December 15, 2000; 165(12): 7042 - 7049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Mummery and C. C. Rider Characterization of the Heparin-Binding Properties of IL-6 J. Immunol., November 15, 2000; 165(10): 5671 - 5679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Auernhammer and S. Melmed Leukemia-Inhibitory Factor--Neuroimmune Modulator of Endocrine Function Endocr. Rev., June 1, 2000; 21(3): 313 - 345. [Abstract] [Full Text]
|
|
|
|
|
|
G. Muller-Newen, A. Kuster, J. Wijdenes, F. Schaper, and P. C. Heinrich Studies on the Interleukin-6-type Cytokine Signal Transducer gp130 Reveal a Novel Mechanism of Receptor Activation by Monoclonal Antibodies J. Biol. Chem., February 18, 2000; 275(7): 4579 - 4586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wan, H. Wang, and J. Nicholas Human Herpesvirus 8 Interleukin-6 (vIL-6) Signals through gp130 but Has Structural and Receptor-Binding Properties Distinct from Those of Human IL-6 J. Virol., October 1, 1999; 73(10): 8268 - 8278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. R. Kaleeba, E. P. Bergquam, and S. W. Wong A Rhesus Macaque Rhadinovirus Related to Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 Encodes a Functional Homologue of Interleukin-6 J. Virol., July 1, 1999; 73(7): 6177 - 6181. [Abstract] [Full Text]
|
|
|
|
|
|
J. E. Layton, G. Shimamoto, T. Osslund, A. Hammacher, D. K. Smith, H. R. Treutlein, and T. Boone Interaction of Granulocyte Colony-stimulating Factor (G-CSF) with Its Receptor. EVIDENCE THAT Glu19 of G-CSF INTERACTS WITH Arg288 OF THE RECEPTOR J. Biol. Chem., June 18, 1999; 274(25): 17445 - 17451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Taupin, V. Miossec, V. Pitard, F. Blanchard, S. Daburon, S. Raher, Y. Jacques, A. Godard, and J.-F. Moreau Binding of Leukemia Inhibitory Factor (LIF) to Mutants of Its Low Affinity Receptor, gp190, Reveals a LIF Binding Site Outside and Interactions between the Two Cytokine Binding Domains J. Biol. Chem., May 14, 1999; 274(20): 14482 - 14489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-J. Kallen, J. Grotzinger, E. Lelievre, P. Vollmer, D. Aasland, C. Renne, J. Mullberg, K.-H. M. zum Buschenfelde, H. Gascan, and S. Rose-John Receptor Recognition Sites of Cytokines Are Organized as Exchangeable Modules. TRANSFER OF THE LEUKEMIA INHIBITORY FACTOR RECEPTOR-BINDING SITE FROM CILIARY NEUROTROPHIC FACTOR TO INTERLEUKIN-6 J. Biol. Chem., April 23, 1999; 274(17): 11859 - 11867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Cole, N. E. Hall, H. R. Treutlein, J. S. Eddes, G. E. Reid, R. L. Moritz, and R. J. Simpson Disulfide Bond Structure and N-Glycosylation Sites of the Extracellular Domain of the Human Interleukin-6 Receptor J. Biol. Chem., March 12, 1999; 274(11): 7207 - 7215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Barton, K. R. Hudson, and J. K. Heath Identification of Three Distinct Receptor Binding Sites of Murine Interleukin-11 J. Biol. Chem., February 26, 1999; 274(9): 5755 - 5761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Kurth, U. Horsten, S. Pflanz, H. Dahmen, A. Kuster, J. Grotzinger, P. C. Heinrich, and G. Muller-Newen Activation of the Signal Transducer Glycoprotein 130 by Both IL-6 and IL-11 Requires Two Distinct Binding Epitopes J. Immunol., February 1, 1999; 162(3): 1480 - 1487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hammacher, R. T. Richardson, J. E. Layton, D. K. Smith, L. J. L. Angus, D. J. Hilton, N. A. Nicola, J. Wijdenes, and R. J. Simpson The Immunoglobulin-like Module of gp130 Is Required for Signaling by Interleukin-6, but Not by Leukemia Inhibitory Factor J. Biol. Chem., August 28, 1998; 273(35): 22701 - 22707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ozbek, J. Grotzinger, B. Krebs, M. Fischer, A. Wollmer, T. Jostock, J. Mullberg, and S. Rose-John The Membrane Proximal Cytokine Receptor Domain of the Human Interleukin-6 Receptor Is Sufficient for Ligand Binding but Not for gp130 Association J. Biol. Chem., August 14, 1998; 273(33): 21374 - 21379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Barton, M. A. Hall, K. R. Hudson, and J. K. Heath Interleukin-11 Signals through the Formation of a Hexameric Receptor Complex J. Biol. Chem., November 10, 2000; 275(46): 36197 - 36203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Moritz, N. E. Hall, L. M. Connolly, and R. J. Simpson Determination of the Disulfide Structure and N-Glycosylation Sites of the Extracellular Domain of the Human Signal Transducer gp130 J. Biol. Chem., March 9, 2001; 276(11): 8244 - 8253. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
